261 related articles for article (PubMed ID: 15355801)
21. Acute myeloid leukemia.
Heerema-McKenney A; Arber DA
Hematol Oncol Clin North Am; 2009 Aug; 23(4):633-54. PubMed ID: 19577162
[TBL] [Abstract][Full Text] [Related]
22. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
[TBL] [Abstract][Full Text] [Related]
23. The new World Health Organization classification of myeloid neoplasms: Q&A with James W. Vardiman, MD.
Vardiman JW
Clin Adv Hematol Oncol; 2003 Jan; 1(1):18, 21. PubMed ID: 16227955
[No Abstract] [Full Text] [Related]
24. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
Germing U; Strupp C; Kuendgen A; Isa S; Knipp S; Hildebrandt B; Giagounidis A; Aul C; Gattermann N; Haas R
Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595
[TBL] [Abstract][Full Text] [Related]
25. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.
Bernasconi P; Klersy C; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Dambruoso I; Lazzarino M; Bernasconi C
Br J Haematol; 2007 May; 137(3):193-205. PubMed ID: 17408458
[TBL] [Abstract][Full Text] [Related]
26. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
[TBL] [Abstract][Full Text] [Related]
27. The classification of MDS: from FAB to WHO and beyond.
Vardiman J
Leuk Res; 2012 Dec; 36(12):1453-8. PubMed ID: 22940257
[TBL] [Abstract][Full Text] [Related]
28. Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases.
Beyer V; Mühlematter D; Parlier V; Cabrol C; Bougeon-Mamin S; Solenthaler M; Tobler A; Pugin P; Gregor M; Hitz F; Hess U; Chapuis B; Laurencet F; Schanz U; Schmidt PM; van Melle G; Jotterand M
Cancer Genet Cytogenet; 2005 Jul; 160(2):97-119. PubMed ID: 15993266
[TBL] [Abstract][Full Text] [Related]
29. [Haematological characteristics, FAB and WHO classification of 153 cases of myeloid acute leukaemia in Tunisia].
Braham-Jmili N; Sendi-Senana H; Labiadh S; Ben Abdelali R; Ben Abdelaziz A; Khelif A; Saad A; Kortas M
Ann Biol Clin (Paris); 2006; 64(5):457-65. PubMed ID: 17040877
[TBL] [Abstract][Full Text] [Related]
30. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
Vardiman JW; Thiele J; Arber DA; Brunning RD; Borowitz MJ; Porwit A; Harris NL; Le Beau MM; Hellström-Lindberg E; Tefferi A; Bloomfield CD
Blood; 2009 Jul; 114(5):937-51. PubMed ID: 19357394
[TBL] [Abstract][Full Text] [Related]
31. [Malignant lymphoma and leukemia concepts in new WHO classification].
Kikuchi M
Rinsho Byori; 2003 Aug; 51(8):820-4. PubMed ID: 13677944
[TBL] [Abstract][Full Text] [Related]
32. The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England.
Phekoo KJ; Richards MA; Møller H; Schey SA;
Haematologica; 2006 Oct; 91(10):1400-4. PubMed ID: 17018393
[TBL] [Abstract][Full Text] [Related]
33. The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.
Anastasi J
Hematol Oncol Clin North Am; 2009 Aug; 23(4):693-708. PubMed ID: 19577165
[TBL] [Abstract][Full Text] [Related]
34. Acute leukemias: a paradigm for the integration of new technologies in diagnosis and classification.
Willman CL
Mod Pathol; 1999 Feb; 12(2):218-28. PubMed ID: 10071344
[TBL] [Abstract][Full Text] [Related]
35. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
[TBL] [Abstract][Full Text] [Related]
36. Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.
Pinto GR; Overal DJ; Moraes LS; Van Den Berg AV; Lemos JA; Smith Mde A; Burbano RR
Genet Mol Res; 2005 Mar; 4(1):18-30. PubMed ID: 15841432
[TBL] [Abstract][Full Text] [Related]
37. The clinical implications of the World Health Organization's classification of myelodysplastic syndromes.
Komrokji RS; Bennett JM
Curr Hematol Rep; 2005 May; 4(3):175-81. PubMed ID: 15865868
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of del(20q) in patients with hematological malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
[TBL] [Abstract][Full Text] [Related]
39. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
[TBL] [Abstract][Full Text] [Related]
40. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J
Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
